Newsby HottubFor agents

Medical Daily

Every GLP-1 Drug Label, Including Ozempic and Zepbound, Must Warn of Rare Sudden Vision Loss in One Eye

The FDA is requiring all GLP-1 drug labels to warn of a potential increased risk of rare eye condition NAION, while advising patients not to stop treatment without medical guidance.

Add to CRM by Hottub

Everyone in this article who could become a relationship. Add opens CRM by Hottub's form, filled in; nothing is saved until you press Add there.

  • Medical DailyOutlet
    Add